Fetomaternal microchimerism in tissue repair and tumor development

Dev Cell. 2022 Jun 20;57(12):1442-1452. doi: 10.1016/j.devcel.2022.05.018. Epub 2022 Jun 13.

Abstract

In various placental mammals, the bidirectional exchange of cells during pregnancy can lead to the acquisition of genetically unique cells that can persist in both mother and child for decades. Over the years, it has become increasingly clear that this phenomenon, termed fetomaternal microchimerism may play key roles in a number of biological processes. In this perspective, we explore the concept of fetomaternal microchimerism and outline how fetal microchimeric cells are detected and immunologically tolerated within the maternal setting. Moreover, we discuss undertakings in the field that hint at the significant plasticity of fetal microchimeric cells and their potential roles in promoting maternal wound healing. Finally, we explore the multifaceted roles of fetal microchimeric cells in cancer development and progression. A deeper understanding of fetomaternal chimerism in healthy and diseased states will be key toward developing more efficient anti-cancer treatments and regenerative therapies.

Keywords: cancer; chimera; fetomaternal microchimerism; regeneration; tissue repair.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Child
  • Chimerism*
  • Female
  • Fetus
  • Humans
  • Mammals
  • Maternal-Fetal Exchange
  • Neoplasms* / genetics
  • Placenta
  • Pregnancy
  • Wound Healing